DUNCAN BARBARA GAYLE received a stock award from HALOZYME THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/2/2025ACC: 0001415889-25-011769
Director
Since Feb 2023
+9.91K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
9.91K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.17K
Price / share
—
Trade value
—
% of position
26.4%
5/1/2025
15.75K→19.92K
Total
Net shares
+4.17K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2025 | A · Award | +4.17K | — | — | 26.4% | 15.75K | 19.92K |
| Total | +4.17K | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
5.75K shares
Shares
+5.75K
Strike price
60.03
Held after
5.75K
Exercisable
—
5/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock5.75K shares | 5/1/2025 | A · Award | +5.75K | 60.03 | — | 5.75K |